Checkpoint Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2017

Stockholders' Equity Note [Abstract]

Nonvested Restricted Stock Shares Activity [Table Text Block]

The following table summarizes restricted stock award activity for the three months ended March 31, 2017.

	Number of Units		Weighted Average Grant Date Fair Value
Nonvested at December 31, 2016		2,533,063	$	2.93
Granted		70,000		5.43
Vested		(70,313)		0.07
Nonvested at March 31, 2017		2,532,750	$	3.07

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

The following table summarizes stock option award activity for the three months ended March 31, 2017:

			Weighted Average		Weighted Average Remaining Contractual Life
	Stock Options		Exercise Price		(in years)
Outstanding as of December 31, 2016		60,000	$	5.43		9.96
Granted		-		-
Outstanding as of March 31, 2017		60,000	$	5.43		9.84

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

A summary of warrant activities for the three months ended March 31, 2017 is presented below:

			Weighted Average		Weighted Average Remaining Contractual Life
	Warrants		Exercise Price		(in years)
Outstanding as of December 31, 2016		4,331,106	$	6.62		4.67
Granted		-		-
Outstanding as of March 31, 2017		4,331,106	$	6.62		4.42

Schedule of Share-based Compensation, Activity [Table Text Block]

Stock-Based Compensation

The following table summarizes stock-based compensation expense for the three months ended March 31, 2017 and 2016 (in thousands).

	For the three months ended March 31,
	2017		2016
Research and development	$	406	$	767
General and administrative		573		321
Total stock-based compensation expense	$	979	$	1,088

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details